Cargando…
Novel Therapeutic Strategies Exploiting the Unique Properties of Neuroendocrine Neoplasms
SIMPLE SUMMARY: The screening of experimental and repurposing drugs has enormous potential for rapid clinical impact, particularly when new therapeutic strategies are sought. By screening two drug libraries, nicotinamide phosphoribosyltransferase (NAMPT) and histone deacetylase (HDAC) inhibitors wer...
Autores principales: | Safari, Maryam, Scotto, Luigi, Litman, Thomas, Petrukhin, Lubov A., Zhu, Hu, Shen, Min, Robey, Robert W., Hall, Matthew D., Fojo, Tito, Bates, Susan E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10605125/ https://www.ncbi.nlm.nih.gov/pubmed/37894327 http://dx.doi.org/10.3390/cancers15204960 |
Ejemplares similares
-
R-Loop–Mediated ssDNA Breaks Accumulate Following Short-Term Exposure to the HDAC Inhibitor Romidepsin
por: Safari, Maryam, et al.
Publicado: (2021) -
Therapeutic strategies for gastroenteropancreatic neuroendocrine neoplasms: State-of-the-art and future perspectives
por: Merola, Elettra, et al.
Publicado: (2022) -
The Mutational, Prognostic, and Therapeutic Landscape of Neuroendocrine Neoplasms
por: Liu, Man, et al.
Publicado: (2023) -
Challenges in High-grade Neuroendocrine Neoplasms and Mixed Neuroendocrine/Non-neuroendocrine Neoplasms
por: La Rosa, Stefano
Publicado: (2021) -
Palatine tonsil metastasis of cecal mixed neuroendocrine‐non‐neuroendocrine neoplasm (MiNEN): A unique case
por: Tsakiraki, Zoi, et al.
Publicado: (2021)